Gabapentin
- Product NDC
- 0615-8230
- 11-digit product format
- 006158230
- Labeler code
- 0615
- Product ID
- 0615-8230_aa7f8790-8a5d-482c-acb2-5e44a1e8174c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA078787
- Marketing category
- ANDA
- Marketing start
- 2008-01-31
- Marketing end
- 2022-03-31
- Substance
- GABAPENTIN
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0615-8230-05 | 00615823005 | 15 CAPSULE in 1 BLISTER PACK (0615-8230-05) | 15 capsule | 2019-06-14 | 2022-03-31 | No | No | Current |
| 0615-8230-30 | 00615823030 | 6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-8230-30) > 5 CAPSULE in 1 BLISTER PACK | 6 blister pack | 2019-06-19 | 2022-03-31 | No | No | Current |
| 0615-8230-39 | 00615823039 | 30 CAPSULE in 1 BLISTER PACK (0615-8230-39) | 30 capsule | 2019-06-14 | 2022-03-31 | No | No | Current |